A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer.
How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed
For years, the playbook for many companies that wanted to market digital therapeutics was stupid simple: Sell it like a prescription drug. But just because